Increased Signal Intensity in the Dentate Nucleus of Patients with Multiple Sclerosis in Comparison with Neuromyelitis Optica Spectrum Disorder after Multiple Doses of Gadolinium Contrast

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Neurology

• Publication date

  2016-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000445431PMID 27054693
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents.

  2015cited by this paper
• T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats

  2015cited by this paper
• Hyperintense Dentate Nuclei on T1-Weighted MRI: Relation to Repeat Gadolinium Administration

  2015cited by this paper
• High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.

  2015cited by this paper
• Commentary on T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.

  2015cited by this paper
• Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent.

  2015cited by this paper
• International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

  2015cited by this paper
• Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging.

  2015cited by this paper
• High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.

  2014cited by this paper
• Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

  2011cited by this paper
• Multiple sclerosis: hyperintense dentate nucleus on unenhanced T1-weighted MR images is associated with the secondary progressive subtype.

  2009cited by this paper
• Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions

  2007cited by this paper
• Neurotoxic effects of gadopentetate dimeglumine: behavioral disturbance and morphology after intracerebroventricular injection in rats.

  1996cited by this paper

• The benefits and side effects of gadolinium-based contrast agents in multiple sclerosis patients

  2022cites this paper
• Does Gadolinium Deposition Lead to Metabolite Alteration in the Dentate Nucleus? An MRS Study in Patients with MS

  2022cites this paper
• Analysis of the Gadolinium retention in the Experimental Autoimmune Encephalomyelitis (EAE) murine model of Multiple Sclerosis.

  2021cites this paper
• Signal Intensity Evaluation in the Dentate Nucleus and Subcortical Gray Matter

  2021cites this paper
• Absence of T1 Hyperintensity in the Brain of High-risk Patients After Multiple Administrations of High-dose Gadobutrol for Cardiac Magnetic Resonance

  2020cites this paper
• Signal changes in enhanced T1-weighted images related to gadolinium retention: a three-time-point imaging study.

  2020cites this paper
• Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents

  2020cites this paper
• Performance diagnostique d'un examen IRM sans injection de produit de contraste dans le suivi évolutif des gliomes des voies optiques chez l'enfant

  2019cites this paper
• Use of gadolinium contrast agents in paediatric population: Donald Rumsfeld meets Hippocrates!

  2019cites this paper
• Patents on Quantitative Susceptibility Mapping (QSM) of Tissue Magnetism.

  2019cites this paper
• Cumulative administrations of gadolinium-based contrast agents: risks of accumulation and toxicity of linear vs macrocyclic agents

  2019cites this paper
• Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS

  2019influential citation
• Toxic-induced cerebellar syndrome: from the fetal period to the elderly.

  2018cites this paper
• Standardized assessment of the signal intensity increase on unenhanced T1-weighted images in the brain: the European Gadolinium Retention Evaluation Consortium (GREC) Task Force position statement

  2018cites this paper
• Re: Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients

  2018cites this paper
• Gadolinium Deposition in the Brain: Current Updates

  2018cites this paper
• Gadolinium Deposition in Brain: Current Scientific Evidence and Future Perspectives

  2018cites this paper
• Gadolinium containing contrast agents-EMEA/H/A-31/1437

  2017cites this paper
• Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients

  2017cites this paper
• Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus

  2017cites this paper
• The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review

  2017cites this paper
• Gadolinium retention in the body: what we know and what we can do

  2017cites this paper
• Technical aspects of MRI signal change quantification after gadolinium-based contrast agents' administration.

  2016cites this paper
• GE Healthcare OmniscanTM (gadodiamide) Injection NDA 20-123 Briefing Document for MIDAC

  year unknowncites this paper